The COVID-19 pandemic has had a huge impact on healthcare systems around the world, in large part due to the need for capacity to treat COVID cases, which has also had significant effects on non-COVID activity. We previously looked at how the pandemic has affected society, healthcare systems and the life sciences industry. We know that the effects have manifested in different ways across different areas, which is why we are now taking a closer look at how COVID-19 has impacted different patient segments at different stages of the pathway. Specifically, we have mapped out the changes experienced by various patient segments including the mostly healthy and the most at-risk groups (patients with priority acute conditions, cancer, mental health and multiple long-term conditions), against different stages of the pathway (prevalence, access/diagnosis, treatment and post-treatment/recovery).
Read the full insight on the CF website